• Publications
  • Influence
Medicament having activation inhibitory action of transcription factors klf5
Inhibiting the activation of transcription factor KLF5, a medicament having action to inhibit vascular remodeling and arteriosclerosis, acyclic polyprenyl compound (e.g., 3,7,11,15-tetramethyl-2,4,Expand
...
1
2
...